| Name | Title | Contact Details |
|---|
Constructor Search improves ecommerce revenue and relevance. Deliver superior onsite and in-app search experiences with AI, NLP, data and personalization. AI-first site search that increases conversions and revenue. Constructor.io
Founded in 2014, x.ai makes an artificial intelligence personal assistant who schedules meetings for you. We`re backed by blue chip investors, including IA Ventures, Firstmark, and Two Sigma Ventures, and located in New York City. We`re a hardcore technology company, developing invisible software. We build our business sustainably through passionate and loyal customers—and every single team member, scientist or not, has a mission of delivering exceptional customer service at all times.
All Pioneer Bank commercial loans are approved locally, allowing you to get on your way and grow your business. Our lending specialists have the resources and local knowledge to help you secure financing solutions that meet your specific needs.
ATEN offers a very tangible edge in innovation. We remain the only KVM vendor with a proprietary Application Specific Integrated Chip (ASIC) to deliver cutting-edge, branded and OEM KVM solutions at lower cost while not compromising high quality and
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.